Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
5
Total Funding
$70.1M
Investors
5 investors across all rounds
5V
5AM Ventures
MC
Monograph Capital
NI
National Institute of Diabetes and Digestive and Kidney Diseases
O
OrbiMed
PE_BUYOUT
UN
US National Science Foundation

ProLynx Leadership & Investors

ProLynx is led by a team of experienced leaders. The company has attracted investment from 5 institutional and strategic investors.

Who Has Invested in ProLynx?

ProLynx has raised $70.1M from 5 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access ProLynx shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.